RT @LluisMontoliu: In this article by @ericsmalley in @NatureBiotech the @ArrigeOrg initiative we launched in Paris in March is inteoduced,…
RT @NatureBiotech: As #CRISPR–Cas adoption soars, summit calls for #genomeediting oversight - @ericsmalley https://t.co/TMTLkZFHPQ https://…
RT @LluisMontoliu: In this article by @ericsmalley in @NatureBiotech the @ArrigeOrg initiative we launched in Paris in March is inteoduced,…
RT @NatureBiotech: As #CRISPR–Cas adoption soars, summit calls for #genomeediting oversight - @ericsmalley https://t.co/TMTLkZFHPQ https://…
RT @LluisMontoliu: In this article by @ericsmalley in @NatureBiotech the @ArrigeOrg initiative we launched in Paris in March is inteoduced,…
RT @NatureBiotech: As #CRISPR–Cas adoption soars, summit calls for #genomeediting oversight - @ericsmalley https://t.co/TMTLkZFHPQ https://…
RT @LluisMontoliu: In this article by @ericsmalley in @NatureBiotech the @ArrigeOrg initiative we launched in Paris in March is inteoduced,…
RT @LluisMontoliu: In this article by @ericsmalley in @NatureBiotech the @ArrigeOrg initiative we launched in Paris in March is inteoduced,…
RT @NatureBiotech: As #CRISPR–Cas adoption soars, summit calls for #genomeediting oversight - @ericsmalley https://t.co/TMTLkZFHPQ https://…
RT @NatureBiotech: As #CRISPR–Cas adoption soars, summit calls for #genomeediting oversight - @ericsmalley https://t.co/TMTLkZFHPQ https://…
RT @NatureBiotech: As #CRISPR–Cas adoption soars, summit calls for #genomeediting oversight - @ericsmalley https://t.co/TMTLkZFHPQ https://…
RT @LluisMontoliu: In this article by @ericsmalley in @NatureBiotech the @ArrigeOrg initiative we launched in Paris in March is inteoduced,…
RT @NatureBiotech: As #CRISPR–Cas adoption soars, summit calls for #genomeediting oversight - @ericsmalley https://t.co/TMTLkZFHPQ https://…
In this article by @ericsmalley in @NatureBiotech the @ArrigeOrg initiative we launched in Paris in March is inteoduced, along with other similar projects. Thanks for your interest and the coverage of the responsible use of genome-editing techniques #RRI h
RT @NatureBiotech: As #CRISPR–Cas adoption soars, summit calls for #genomeediting oversight - @ericsmalley https://t.co/TMTLkZFHPQ https://…
RT @NatureBiotech: As #CRISPR–Cas adoption soars, summit calls for #genomeediting oversight - @ericsmalley https://t.co/TMTLkZFHPQ https://…
RT @NatureBiotech: As #CRISPR–Cas adoption soars, summit calls for #genomeediting oversight - @ericsmalley https://t.co/TMTLkZFHPQ https://…
RT @NatureBiotech: As #CRISPR–Cas adoption soars, summit calls for #genomeediting oversight - @ericsmalley https://t.co/TMTLkZFHPQ https://…
RT @NatureBiotech: As #CRISPR–Cas adoption soars, summit calls for #genomeediting oversight - @ericsmalley https://t.co/TMTLkZFHPQ https://…
RT @NatureBiotech: As #CRISPR–Cas adoption soars, summit calls for #genomeediting oversight - @ericsmalley https://t.co/TMTLkZFHPQ https://…
RT @NatureBiotech: As #CRISPR–Cas adoption soars, summit calls for #genomeediting oversight - @ericsmalley https://t.co/TMTLkZFHPQ https://…
RT @NatureBiotech: As #CRISPR–Cas adoption soars, summit calls for #genomeediting oversight - @ericsmalley https://t.co/TMTLkZFHPQ https://…
As #CRISPR–Cas adoption soars, summit calls for #genomeediting oversight - @ericsmalley https://t.co/TMTLkZFHPQ https://t.co/NEvZ0VpezF
RT @CSarrauste: the ARRIGE initiative @ArrigeOrg is commented in this article in Nature Biotechnology @NatureBiotech by Eric Smalley http…
RT @CSarrauste: the ARRIGE initiative @ArrigeOrg is commented in this article in Nature Biotechnology @NatureBiotech by Eric Smalley http…
RT @CSarrauste: the ARRIGE initiative @ArrigeOrg is commented in this article in Nature Biotechnology @NatureBiotech by Eric Smalley http…
RT @CIBERER: La prestigiosa revista @NatureBiotech publica un artículo de @ericsmalley en el que valora y explica la importancia de iniciat…
RT @LluisMontoliu: The @ArrigeOrg initiative featured in this news&comments article by @ericsmalley in @NatureBiotech A big challenge ahead…
RT @CSarrauste: the ARRIGE initiative @ArrigeOrg is commented in this article in Nature Biotechnology @NatureBiotech by Eric Smalley http…
RT @CIBERER: La prestigiosa revista @NatureBiotech publica un artículo de @ericsmalley en el que valora y explica la importancia de iniciat…
RT @CIBERER: La prestigiosa revista @NatureBiotech publica un artículo de @ericsmalley en el que valora y explica la importancia de iniciat…
RT @CSarrauste: the ARRIGE initiative @ArrigeOrg is commented in this article in Nature Biotechnology @NatureBiotech by Eric Smalley http…
the ARRIGE initiative @ArrigeOrg is commented in this article in Nature Biotechnology @NatureBiotech by Eric Smalley https://t.co/QH4N4GIlGT
RT @LluisMontoliu: The @ArrigeOrg initiative featured in this news&comments article by @ericsmalley in @NatureBiotech A big challenge ahead…
La prestigiosa revista @NatureBiotech publica un artículo de @ericsmalley en el que valora y explica la importancia de iniciativas como @ArrigeOrg, lanzada para promover una gobernanza global en la #edicióngénica https://t.co/HK9h43fhMr @LluisMontoliu
RT @LluisMontoliu: The @ArrigeOrg initiative featured in this news&comments article by @ericsmalley in @NatureBiotech A big challenge ahead…
RT @LluisMontoliu: The @ArrigeOrg initiative featured in this news&comments article by @ericsmalley in @NatureBiotech A big challenge ahead…
RT @LluisMontoliu: The @ArrigeOrg initiative featured in this news&comments article by @ericsmalley in @NatureBiotech A big challenge ahead…
RT @LluisMontoliu: The @ArrigeOrg initiative featured in this news&comments article by @ericsmalley in @NatureBiotech A big challenge ahead…
RT @LluisMontoliu: The @ArrigeOrg initiative featured in this news&comments article by @ericsmalley in @NatureBiotech A big challenge ahead…
RT @LluisMontoliu: The @ArrigeOrg initiative featured in this news&comments article by @ericsmalley in @NatureBiotech A big challenge ahead…
RT @LluisMontoliu: The @ArrigeOrg initiative featured in this news&comments article by @ericsmalley in @NatureBiotech A big challenge ahead…
The @ArrigeOrg initiative featured in this news&comments article by @ericsmalley in @NatureBiotech A big challenge ahead of us but an unavoidable one if we believe in the responsible use of genome editing methods and the engagement of all stakeholders
The position statement “did not condemn experiments to modify human embryos, but urged further discussions about safety and ethics, and efforts to harmonize regulation of the use of CRISPR–Cas9 and other genome editing technologies.” https://t.co/5JbD0LAuj
[News]As #CRISPR–Cas adoption soars, summit calls for genome editing oversight. Smalley E. Nat Biotechnol. 2018 June 6. https://t.co/0eFZK7aGd5 "ARRIGE & the genome editing observatory ....."